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September 9, 2008:966–70ivo imaging of angiogenesis with the use of contrast-enhanced
ranscutaneous ultrasound sound is promising, as elegantly shown by
hah et al. (4). However, trials with an extended number of human
ubjects and validation of histological angiogenesis are required. These
echnologies may then help to elucidate the close pathophysiological
onnection between intimal and adventitial angiogenesis in human
therosclerosis. Whether or not these technologies are going to be
seful to detect specific plaque stages remains to be investigated.
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ikelihood of Ventricular
rrhythmias Due to Myocardial
ibrosis in Hypertrophic
ardiomyopathy as Detected
y Cardiac Magnetic
esonance Imaging
n a recent study, Adabag et al. (1) have shown that myocardial
brosis detected by cardiovascular magnetic resonance (CMR)
ith delayed enhancement (DE) imaging after gadolinium infu-
ion in a cohort of 177 patients with hypertrophic cardiomyopathy
s associated with greater likelihood and increased frequency of
entricular arrhythmias on ambulatory Holter electrocardiogram
onitoring as compared with those without DE on CMR. They
urther conclude that, contrast-enhanced CMR identifies hyper-
rophic cardiomyopathy patients with increased susceptibility to
entricular arrhythmias.
The study is well performed with good statistical power. However,here is a question regarding the patient population in this study. Ctreit et al. (2) had demonstrated earlier that alcohol septal ablation
as arrhythmogenic potential due to myocardial fibrosis that can
ncrease the frequency of ventricular arrhythmias. These fibrotic areas
n the myocardium caused by septal ablation can potentially give rise
E on CMR. Therefore, history of prior myocardial septostomy or
ercutaneous interventions (i.e., ethanol injection) for the relief of left
entricular outflow obstruction could be an important confounding
ariable that can cause both DE on CMR and ventricular arrhyth-
ias. Adabag et al. (1) did not provide any information on this issue
hat may potentially affect the results. It would be helpful to know
ow many of the patients in the study had procedures done for the
elief of left ventricular obstructions and whether excluding such
atients will provide the same results.
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eply
e appreciate the interest of Dr. Dhoble and colleagues in our
aper (1). Of our reported 177 hypertrophic cardiomyopathy
atients, none had undergone alcohol septal ablation before the
ardiac magnetic resonance study and 24-h ambulatory Holter
lectrocardiogram were performed. Nonetheless, Dr. Dhoble and
olleagues raise an important point. Percutaneous alcohol septal
blation, pioneered in the last decade as a nonsurgical alternative to
urgical myectomy for reduction of left ventricular outflow tract
bstruction and heart failure symptoms in hypertrophic cardiomy-
pathy, intentionally creates a sizable transmural scar in the
eptum (2). Indeed, there is some evidence that alcohol ablation
ncreases the arrhythmia burden in this disease for which some
atients already harbor increased arrhythmogenicity (3). Conse-
uently, alcohol septal ablation is recommended only as a selective
lternative to patients for whom the gold standard surgical septal
yectomy is undesirable (4).
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